Roberto Mendoza-Londono Selected Research

Roberto Mendoza-Londono Research Topics

Disease

3	Intellectual Disability (Idiocy) 01/2020 - 05/2007
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 02/2015
2	Neurodevelopmental Disorders 01/2020 - 01/2016
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 10/2022
1	Monosomy 11/2021
1	Delayed Puberty 11/2021
1	Trisomy (Trisomies) 11/2021
1	Otitis Media 01/2021
1	Bacteremia 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Weaver syndrome 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Cholestasis 01/2019
1	Carcinogenesis 01/2019
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2018
1	Hydrocephalus (Hydrocephaly) 06/2017
1	Congenital Disorders of Glycosylation 01/2017
1	Congenital disorder of glycosylation type II 01/2017
1	Cardiofaciocutaneous syndrome 12/2016
1	Sarcoma (Soft Tissue Sarcoma) 12/2016
1	Precocious Puberty 12/2016
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2016
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 03/2015
1	Muscle Spasticity (Spastic) 03/2015
1	Pyridoxine-dependent epilepsy 02/2015
1	Epilepsy (Aura) 02/2015
1	Movement Disorders (Movement Disorder) 02/2015
1	Dwarfism 12/2014
1	Spondyloepimetaphyseal Dysplasia With Joint Laxity 06/2013
1	Angelman Syndrome (Syndrome, Angelman) 03/2013
1	Osteopathia striata cranial sclerosis 11/2012
1	Type I Plasminogen Deficiency 03/2011
1	Joint Dislocations 10/2010
1	Desbuquois syndrome 10/2010
1	Larsen Syndrome 10/2010
1	Omani type Spondyloepiphyseal dysplasia 10/2010
1	Liver Diseases (Liver Disease) 07/2010
1	Smith-Magenis Syndrome 05/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2005
1	Leukemia 01/2005
1	Pallister-Hall Syndrome 01/2005

Drug/Important Bio-Agent (IBA)

2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2005
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Albuterol (Salbutamol)FDA LinkGeneric 10/2022
1	Growth Hormone (Somatotropin)IBA 11/2021
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2021
1	Histone MethyltransferasesIBA 01/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2019
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 01/2019
1	Monomeric GTP-Binding ProteinsIBA 01/2018
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 06/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Congenital disorder of glycosylation type 1AIBA 01/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2017
1	Polysaccharides (Glycans)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 12/2016
1	NucleotidesIBA 01/2016
1	UtrophinIBA 01/2016
1	Fetal Proteins (Fetoprotein)IBA 03/2015
1	Phosphates (Orthophosphate)IBA 02/2015
1	Dihydropteridine Reductase (6,7 Dihydropteridine Reductase)IBA 02/2015
1	Guanosine Triphosphate (GTP)IBA 02/2015
1	Oxidoreductases (Dehydrogenase)IBA 02/2015
1	tetrahydropterinIBA 02/2015
1	PyridoxamineIBA 02/2015
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 02/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2015
1	Phosphotransferases (Kinase)IBA 12/2014
1	EnzymesIBA 06/2013
1	Terminator Codon (Termination Codon)IBA 03/2013
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 11/2012
1	PlasminogenIBA 03/2011
1	Ophthalmic Solutions (Eye Drops)IBA 03/2011
1	Heparin (Liquaemin)FDA LinkGeneric 03/2011
1	FilaminsIBA 10/2010
1	ChondroitinIBA 10/2010
1	SulfotransferasesIBA 10/2010
1	Carbohydrate SulfotransferasesIBA 10/2010
1	Alkaline PhosphataseIBA 07/2010
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2007
1	Proteins (Proteins, Gene)FDA Link 01/2005

Therapy/Procedure

1	Mechanical Ventilators (Ventilator) 01/2020
1	Intravenous Administration 01/2020
1	Liver Transplantation 01/2019
1	Stem Cell Transplantation 01/2005